ArticleEClinicalMedicine2026

AAV9-mediated GAA gene therapy following enzyme replacement therapy discontinuation in children with infantile-onset Pompe disease.

Xinting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.